Source abstract
Abstract
Abstract Self‐assembled protein nanoparticles have attracted much attention in biomedicine because of their biocompatibility and biodegradability. Protein nanoparticles have become widely utilized as diagnostic or therapeutic agents for various cancers. However, there are no reports that protein nanoparticles can specifically target mitochondria. This targeting is desirable, since mitochondria are critical in the development of cancer cells. In this study, the discovery of a novel self‐assembled metal protein nanoparticle, designated GST‐MT‐3, is reported, which targets the mitochondria of cancer cells within 30 min in vitro and rapidly accumulates in tumors within 1 h in vivo. The nanoparticles chelate cobalt ions [GST‐MT‐3(Co2+)], which induces reactive oxygen species (ROS) production and reduces the mitochondrial membrane potential. These effects lead to antitumor activity in vivo. GST‐MT‐3(Co2+) with covalently conjugated paclitaxel synergistically suppress tumors and prolong survival. Importantly, the effective dosage of paclitaxel is 50‐fold lower than that utilized in standard chemotherapy (0.2 vs 10 mg kg−1). To the best of the authors' knowledge, GST‐MT‐3 is the first reported protein nanoparticle that targets mitochondria. It has the potential to be an excellent platform for combination therapies.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Advanced biosensing and bioanalysis techniques · Nanocluster Synthesis and Applications · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Synthetic and Functional Biomolecules Center Beijing National Laboratory for Molecular Sciences Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education College of Chemistry and Molecular Engineering Innovation Center for Genomics Peking University Beijing 100871 China
State Key Laboratory of Agrobiotechnology and College of Veterinary Medicine China Agricultural University Beijing 100094 China
Department of Radiology Clinical College of 307th Hospital of PLA Anhui Medical University 307 Hospital PLA Beijing 100071 China
Beijing Institute of Pharmacology and Toxicology National Beijing Center for Drug Safety Evaluation and Research State Key Laboratory of Toxicology and Medical Countermeasures Academy of Military Medical Sciences Beijing 100850 China
Funding
National Natural Science Foundation of China
References (40)
Show source-provided references
20. Castro I. F. D. · 2014 · 55
39. Zhang Y. M. · Angew. Chem., Int. Ed · 2018